Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$36.13 +0.10 (+0.28%)
At close: Oct 23, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Amortization of Deferred Charges (2019 - 2023)

Updated

Analysis

Harmony Biosciences Holdings (HRMY) Amortization of Deferred Charges (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Harmony Biosciences Holdings 2.10 Bn -656.73 Mn 198.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 424,000.00
Mar 31, 2023 416,000.00
Dec 31, 2022 422,000.00
Sep 30, 2022 418,000.00
Jun 30, 2022 411,000.00
Mar 31, 2022 412,000.00
Dec 31, 2021 418,000.00
Sep 30, 2021 459,000.00
Jun 30, 2021 697,000.00
Mar 31, 2021 664,000.00
Dec 31, 2020 1.39 Mn
Sep 30, 2020 340,000.00
Jun 30, 2020 340,000.00
Mar 31, 2020 340,000.00
Dec 31, 2019 210,000.00
API Access

Harmony Biosciences Holdings Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=HRMY&period=max&api_key=YOUR_API_KEY